LHS.CN - Liberty Health Sciences Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
1.37
+0.08 (+6.20%)
As of 11:25AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close1.29
Open1.32
Bid1.36 x 0
Ask1.37 x 0
Day's Range1.32 - 1.38
52 Week Range0.62 - 2.88
Volume1,500,824
Avg. Volume1,555,275
Market Cap464.44M
Beta4.07
PE Ratio (TTM)N/A
EPS (TTM)-0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group12 days ago

    Liberty Health Sciences Enters Exclusive Partnership With AdaViv To Develop New AI-Driven Analytics For Increased Crop Output

    TORONTO, Sept. 13, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of trusted, high quality cannabis experiences, announced today that they have entered an exclusive partnership with AdaViv Inc., a hardware-enabled, predictive agriculture company, to improve production of cannabis at its Liberty Health Sciences 360 Innovation Campus in Gainesville, FL. AdaViv will integrate its adaptive Computer Vision software and Machine Learning platform into Liberty's 360 Innovation Campus and, together, will look to push the state-of-the-art in greenhouse technology and precision growing to new levels of productivity and efficiency. AdaViv's technology enables 24/7 plant-level inspection as well as AI computer vision to uncover hidden plant biometrics that translates data into actionable insights for growers like Liberty.

  • CNW Group15 days ago

    Liberty Health Sciences Signs Agreement As First State Partner To Bring The Award-Winning PAX Era To The Florida Market

    TORONTO, Sept. 10, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of trusted, high quality cannabis experiences, announced today that it has become the first brand partner for the PAX Era, an easy-to-use, temperature controlled portable cannabis oil vaporizer, in the Florida market. The PAX Era vapor platform and compatible pod technology will be available in all of Liberty's Cannabis Education Centers (CEC) locations and through delivery starting October 1, 2018. Liberty will offer several varieties of strains, designed for a wide array of uses and giving a broad range of choice to consumers.

  • CNW Group19 days ago

    Liberty Health Sciences Experiences Significant Growth In Florida Market, Largest Revenue Increase In Company History

    TORONTO, Sept. 6, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX:LHSIF - News) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today that they experienced a 95% increase in sales revenue in the three-month period ended August 31, 2018 compared to the previous three-month period which ended May 31, 2018. Liberty's recent quarterly revenue totalled $2.2 million compared to $1.1 million for the previous quarter, a 95% increase. The growth in revenue reflects the wider recognition of the Liberty brands in terms of quality and consistency as well as the patient-centric approach that the Company uses.

  • CNW Group21 days ago

    Liberty Health Sciences Taps FlorPass As Florida's First Online Shopping Portal For Its Premium Cannabis Products

    TORONTO, Sept. 4, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX:LHSIF - News) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of trusted, high quality cannabis experiences, announced today that it has received approval by the Florida Department of Health to implement FlorPass as the state's first online patient management system, connecting patients, physicians and cannabis retailers in one system to provide enhanced care. FlorPass is developed by Alternate Health Corp., an international corporation that provides software solutions for the medical cannabis industry. FlorPass is the Florida equivalent of Alternate Health's CanaPass Cannabis Compliance technology, which is currently operational nationwide in Canada.

  • CNW Group25 days ago

    Liberty Health Sciences Approved To Manufacture And Dispense Solei Sungrown Cannabis ("Solei") Products In FL Dispensaries

    TORONTO , Aug. 31, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF ) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, ...

  • CNW Grouplast month

    Liberty Health Sciences Launches Revolutionary New Website

    TORONTO, Aug. 13, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty"), a leader in providing premium pharmaceutical-grade cannabis to consumers, announced today that it has launched its much anticipated new website. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities while keeping consumers' well-being at the forefront of what we do. Liberty has an extensive background in highly regulated industries, with expertise a low-cost producer of premium products. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean, and safe pharmaceutical grade cannabis to consumers.

  • Liberty Health Sciences Doubles Cultivation Capacity With Expansion of Liberty Health Sciences 360º Innovation Campus
    CNW Group2 months ago

    Liberty Health Sciences Doubles Cultivation Capacity With Expansion of Liberty Health Sciences 360º Innovation Campus

    TORONTO, Aug. 7, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX: LHSIF) www.libertycec.com ("Liberty" or the "Company"), a provider of high quality pharmaceutical grade cannabis, announced today that it has doubled its cultivation space in Florida with production commencing at its Liberty Health Sciences 360 Innovation Campus (the "360 Campus") in Gainesville in response to the growing demand by Florida patients. The Company received permission to commence production at the 360 Campus while a retrofit of the facilities is being completed. The Company's Chestnut Hill facility continues to operate at full capacity.

  • Liberty Health Sciences is pleased by Aphria's lock-up agreement on divestiture
    CNW Group2 months ago

    Liberty Health Sciences is pleased by Aphria's lock-up agreement on divestiture

    TORONTO, July 23, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") is pleased to announce Aphria Inc. ("Aphria") has entered into an 18 month lock-up or stand-still agreement with the purchasers of Aphria's shares in Liberty. The divestiture of Liberty stock by Aphria was originally announced on February 5, 2018 as part of Aphria's commitment to the Toronto Stock Exchange.

  • CNW Group3 months ago

    Liberty Health Sciences Issues Stock Options and Shares

    /NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES/ TORONTO , July 4, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty" or the "Company") announced ...

  • Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project
    CNW Group3 months ago

    Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project

    TORONTO, July 3, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE:LHS.CN - News) (OTCQX:LHSIF - News) ("Liberty" or the "Company") is honored to announce its partnership with the Veterans Cannabis Project, an association dedicated to improving US military veterans' quality of life through the opportunity of cannabis. To better provide effective treatment options for those who are serving, and have served, our country in the armed forces, Liberty is collaborating with Veterans Cannabis Project to support vital research projects focused on the treatment of service related trauma with cannabis derived products. In an effort to launch this important alliance and demonstrate the Company's commitment to, and admiration for, veterans nationwide, Liberty will offer a 25% discount on all purchases for armed forces personnel.

  • CNW Group3 months ago

    Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs

    TORONTO , June 29, 2018 /CNW/ - Horizons ETFs Management (Canada ) Inc. (" Horizons ETFs ") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences ...

  • CNW Group3 months ago

    Liberty Health Sciences Earns GMP Certification for Greenhouse and Production Facilities

    TORONTO, June 25, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced it has received Good Manufacturing Practice ("GMP") approval from SAI Global for the Company's ­­greenhouse and production facilities in ­­Alachua County, Florida. The GMP certificate was earned in advance of Liberty's July 5th deadline for its processing facilities, confirming the site's compliance with FDA's food safety and packaging GMPs.

  • CNW Group4 months ago

    Liberty Health Sciences commends Congressional push to let states follow their own cannabis rules

    TORONTO, June 7, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") applauds Senators Elizabeth Warren and Cory Gardner for introducing a bipartisan bill that would lift the Controlled Substance Act's restrictions on cannabis in states that have written their own laws. "This is a game-changer," said Liberty Health Sciences CEO George Scorsis. "Reputable and responsible medical cannabis companies providing important pain relief and treatment options, deserve the right to conduct business in a transparent matter with a full suite of legal protections in states where cannabis is legal.

  • CNW Group4 months ago

    Liberty Health Sciences opens Port St. Lucie's first medical cannabis dispensary

    TORONTO, May 31, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the opening of its Cannabis Education Center ("CEC") in Port St. Lucie, Florida. This is Liberty's fourth CEC to open in the state this year and advances the Company's mission to provide Florida's residents with convenient access to high-quality medical cannabis and patient-focused educational resources.

  • CNW Group4 months ago

    Liberty Health Sciences to be exclusive distributor of Isodiol International products throughout Florida and Massachusetts

    TORONTO, May 30, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") is pleased to announce that it has signed a licensing agreement with Isodiol International Inc. ("Isodiol"), a leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of CBD consumer products, to provide a complementary suite of medical cannabis products to patients in Florida and Massachusetts. "Liberty is proud to team up with Isodiol, a company renowned for its ability to process and extract high purity CBD on an industrial scale," said George Scorsis, Director and CEO of Liberty.

  • CNW Group4 months ago

    Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary's Medicinals Cannabis Products to Massachusetts

    TORONTO, May 25, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the expansion of the Company's partnership with Colorado-based MM Technology Holdings, LLC ("Mary's") to be the exclusive provider of the award-winning line of Mary's Medicinals® cannabis products in Massachusetts. Under the agreement, Liberty will produce and distribute Mary's suite of innovative cannabis products, featuring a variety of novel delivery methods, under license in Massachusetts for both medical and recreational users, when permitted.

  • CNW Group4 months ago

    Liberty Health Sciences Teams Up with Solomon Wilcots for AAMPA's Conference on the NFL and Medical Cannabis

    TORONTO, May 18, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced it has teamed up with Emmy Award-winning NFL broadcaster and retired player Solomon Wilcots.  Mr. Wilcots is speaking this afternoon in Miami at the American Medical Marijuana Physicians Association's ("AAMPA") conference on "The NFL and Medical Cannabis". "Education is critical to helping doctors and the patients they treat understand and benefit from medical cannabis," said George Scorsis, Director and CEO of Liberty.

  • CNW Group4 months ago

    Liberty Health Sciences Continues Rollout of its Cannabis Education Centers with new Location in Tampa, Florida

    TORONTO, May 18, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the successful opening of its Cannabis Education Center ("CEC") in Tampa, Florida. The Tampa location becomes the third CEC to open in the state as part of the Company's strategy to roll its unique patient-centric dispensaries across Florida.

  • Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing
    CNW Group4 months ago

    Liberty Health Sciences names Stephanie Kubacki as Vice President of Marketing

    TORONTO, May 15, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") has named seasoned marketing executive Stephanie Kubacki as Vice President of Marketing, effective June 1, 2018. Ms. Kubacki comes to Liberty with and exceptional track record managing and building high-profile brands in the highly regulated beverage industry. "I am incredibly excited to welcome Stephanie to the leadership team where she will play an important role in pursuing our aggressive growth strategy" said George Scorsis, Director and CEO of Liberty.

  • CNW Group5 months ago

    Liberty Health Sciences to Bring Solei Cannabis Brand to Florida and Massachusetts

    TORONTO, May 11, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced it has signed an amended licensing agreement with Aphria Inc. ("Aphria") to add Solei Sungrown Cannabis ("Solei"), to the Company's growing portfolio of brands. Under the terms of the agreement, Liberty will be able to produce and sell Solei in Florida and Massachusetts, subject to receipt of all required approvals from the Florida Department of Health, Office of Medical Marijuana Use, and from the Commonwealth of Massachusetts, Medical Use of Marijuana Program or the Massachusetts Cannabis Control Commission, if any.

  • CNW Group5 months ago

    Liberty Health Sciences Strengthens Presence in Florida with St. Petersburg Cannabis Education Center

    TORONTO, May 10, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced the successful opening of its second Florida Cannabis Education Center ("CEC") with a grand opening ceremony set for May 17, 2018 at 5:30 pm EST. The St. Petersburg location is strategically located within a five-mile radius of 90 percent of the city's 257,000 residents. "Liberty Health Sciences is proud to be part of the St. Petersburg community and to fulfill our promise to provide the area with our patient-centric approach to cannabis through unparalleled service and educational resources," said George Scorsis, Director and CEO of Liberty.

  • CNW Group5 months ago

    Liberty Health Sciences continues to expand distribution capabilities

    TORONTO, April 13, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") announced today the Company will open its second medical cannabis dispensary in Florida, strategically located in St. Petersburg, a city with a population of 257,083. Pending approval by The Florida Department of Health ("DOH"), the opening is scheduled for April 17. "The opening of our second Florida dispensary demonstrates our ongoing commitment to expand our footprint in the state, making it more convenient for Floridians to access high quality medical cannabis," said CEO George Scorsis.

  • CNW Group5 months ago

    Liberty Health Sciences' sales surge on explosive market growth in early 2018

    TORONTO, April 11, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:LHSIF - News) ("Liberty" or the "Company") today announced that the Company has recorded a 253% increase in monthly revenue since the start of 2018, and a 100% increase in its served patient count. The surge has been fueled by unprecedented growth in the number of registered medical cannabis patients and physicians in the state of Florida.